Financial giants have made a conspicuous bearish move on Johnson & Johnson. Our analysis of options history for Johnson & Johnson (NYSE:JNJ) revealed 12 unusual trades.
Delving into the details, we found 16% of traders were bullish, while 75% showed bearish tendencies. Out of all the trades we spotted, 4 were puts, with a value of $219,995, and 8 were calls, valued at $824,755.
Projected Price Targets
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $150.0 to $230.0 for Johnson & Johnson over the last 3 months.
Volume & Open Interest Trends
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Johnson & Johnson's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Johnson & Johnson's whale activity within a strike price range from $150.0 to $230.0 in the last 30 days.
Johnson & Johnson Call and Put Volume: 30-Day Overview
Largest Options Trades Observed:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| JNJ | CALL | TRADE | BEARISH | 03/20/26 | $20.05 | $19.85 | $19.85 | $190.00 | $297.7K | 3.1K | 1.1K |
| JNJ | CALL | SWEEP | BEARISH | 06/18/26 | $10.75 | $10.3 | $10.3 | $210.00 | $154.5K | 1.3K | 1.1K |
| JNJ | CALL | SWEEP | BEARISH | 12/18/26 | $9.25 | $7.95 | $7.9 | $230.00 | $124.8K | 1.0K | 0 |
| JNJ | PUT | TRADE | BEARISH | 12/18/26 | $6.9 | $4.55 | $6.9 | $175.00 | $109.0K | 42 | 158 |
| JNJ | CALL | TRADE | BEARISH | 03/20/26 | $43.9 | $41.6 | $42.24 | $165.00 | $101.3K | 783 | 25 |
About Johnson & Johnson
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
Where Is Johnson & Johnson Standing Right Now?
- With a volume of 2,917,091, the price of JNJ is up 0.28% at $206.0.
- RSI indicators hint that the underlying stock may be overbought.
- Next earnings are expected to be released in 49 days.
What Analysts Are Saying About Johnson & Johnson
1 market experts have recently issued ratings for this stock, with a consensus target price of $197.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. Click here for access. * Consistent in their evaluation, an analyst from Barclays keeps a Equal-Weight rating on Johnson & Johnson with a target price of $197.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Johnson & Johnson options trades with real-time alerts from Benzinga Pro.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
